(3β,7β,12β,20Z) -3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid
Selected Variant
HY-N8090
Size: 1 mg
(3β,7β,12β,20Z) -3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid, a lanostane triterpenoids, exhibits obvious NO inhibitory activity on n LPS-induced BV-2 microglia cells with an IC50 of 9.55 uM. (3β,7β,12β,20Z) -3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid has anti-inflammatory activities[1].
Product Specifications
CAS Number
1961358-02-0
UNSPSC
12352211
Target
NO Synthase
Type
Natural Products
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/3β-7β-12β-20z-3-7-12-trihydroxy-11-15-23-trioxo-lanost-8-20-dien-26-oic-acid.html
Purity
97.84
Solubility
10 mM in DMSO
Smiles
C[C@]([C@@]([C@H]1/C(C)=C\C(CC(C)C(O)=O)=O)([C@@H]2O)C)(C(C1)=O)C([C@H](C[C@@]3([H])C4(C)C)O)=C(C2=O)[C@]3(CC[C@@H]4O)C
Molecular Formula
C30H42O8
Molecular Weight
530.65
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Progesterone Receptor (Marker of Progestin Dependence) (PGR/2694), CF488A conjugate, 0.1mg/mL
CD9 (TSPAN29) (Motility-Related Protein-1) (P1/33/2), CF640R conjugate, 0.1mg/mL
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), CF405S conjugate, 0.1mg/mL
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), 1mg/mL
Factor XIIIa (Coagulation Factor XIIIA Chain) (F13A1/1448), CF405S conjugate, 0.1mg/mL
